OR WAIT null SECS
May 15, 2017
Manufacturing for originator molecules is restricted by regulations, but drug makers can exploit newer technologies for the manufacture of biosimilars.
May 05, 2017
EMA and the European Commission released a biosimilars information guide for health professionals during the EC’s biosimilars conference.
Forecasts were lowered, Reuters reported, due to reduced drug approvals and increased competitive pressures.
April 24, 2017
Companies believe that biologics and biosimilars would experience the fastest growth over the next year; there is also interest on increasing market penetration of generic drugs.
Sandoz, a Novartis division, announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted positive opinions recommending the approval of its biosimilars rituximab and etanercept in Europe, for the same indications as the respective reference medicines.
April 18, 2017
The funding allows the company to broaden its range of services and finance its move to new laboratory facilities in the Illkirch-Graffenstaden innovation park in northeast France.
April 05, 2017
Researchers continue efforts to overcome challenges of effective oral delivery of biologic drugs.
April 02, 2017
New study shows China biopharma companies face staffing shortages.
The transfer of fluids is governed by different equipment requirements across the medical, biopharma, and cell therapy manufacturing industries.
The process control and automation requirements of single-use systems differ from those of stainless-steel equipment.